GlassScriptPhysician profile
Ali Khavari
NPI 1043836778
$2,881.21
in general payments reported to CMS, 2019-2025
12 companies · $1,725 in 2025
The $1,725 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,156 · 2025: $1,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,954 · Travel and Lodging: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,953.60 |
| Travel and Lodging | $927.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,438.33 | 2024-2025 | Bun-Yo-Matic, Portfolio, Phantom Fibula Nail |
| Kerecis Limited | $449.85 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Mimedx Group, INC. | $208.55 | 2024-2025 | |
| Bioventus LLC | $177.70 | 2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $161.60 | 2024 | Stravix, Grafix Pl, Stravix Pl |
| Depuy Synthes Sales INC. | $113.47 | 2025 | Motoband |
| Stryker Corporation | $105.25 | 2024-2025 | Salvation, N/A, Augment Injectable |
| Bone Support INC. | $80.83 | 2025 | Ceramentbone Void Filler, Cerament G |
| Evolution Surgical, INC | $48.28 | 2024 | |
| Averitas Pharma INC. | $39.47 | 2024 | Qutenza |
| Orthofix Medical, INC. | $32.61 | 2025 | Physio-Stim |
| Solventum Corporation | $25.27 | 2024 | Activ.A.C., Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Khavari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.